BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 7893624)

  • 1. Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.
    Strakowski SM; Tohen M; Flaum M; Amador X
    Schizophr Res; 1994 Dec; 14(1):73-81. PubMed ID: 7893624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The deficit syndrome in the DSM-IV Field Trial: I. Alcohol and other drug abuse.
    Kirkpatrick B; Amador XF; Flaum M; Yale SA; Gorman JM; Carpenter WT; Tohen M; McGlashan T
    Schizophr Res; 1996 May; 20(1-2):69-77. PubMed ID: 8794495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative study of substance dependence comorbidity in bipolar, schizophrenic and schizoaffective disorders].
    Verdoux H; Mury M; Besançon G; Bourgeois M
    Encephale; 1996; 22(2):95-101. PubMed ID: 8706627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.
    Brunette MF; Noordsy DL; Xie H; Drake RE
    Psychiatr Serv; 2003 Oct; 54(10):1395-401. PubMed ID: 14557527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronology of comorbid and principal syndromes in first-episode psychosis.
    Strakowski SM; Keck PE; McElroy SL; Lonczak HS; West SA
    Compr Psychiatry; 1995; 36(2):106-12. PubMed ID: 7758295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder.
    Mueser KT; Yarnold PR; Bellack AS
    Acta Psychiatr Scand; 1992 Jan; 85(1):48-55. PubMed ID: 1546548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness.
    Warner R; Taylor D; Wright J; Sloat A; Springett G; Arnold S; Weinberg H
    Am J Orthopsychiatry; 1994 Jan; 64(1):30-9. PubMed ID: 8147425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and severity of substance use disorders and onset of psychosis in first-admission psychotic patients.
    Rabinowitz J; Bromet EJ; Lavelle J; Carlson G; Kovasznay B; Schwartz JE
    Psychol Med; 1998 Nov; 28(6):1411-9. PubMed ID: 9854282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid substance abuse and recovery from acute psychiatric relapse.
    Sanguineti VR; Samuel SE
    Hosp Community Psychiatry; 1993 Nov; 44(11):1073-6. PubMed ID: 8288176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent validity of clinicians' ratings of substance abuse among psychiatric outpatients.
    Carey KB; Cocco KM; Simons JS
    Psychiatr Serv; 1996 Aug; 47(8):842-7. PubMed ID: 8837156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expectations and motives for substance use in schizophrenia.
    Mueser KT; Nishith P; Tracy JI; DeGirolamo J; Molinaro M
    Schizophr Bull; 1995; 21(3):367-78. PubMed ID: 7481568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substance abuse and onset of psychotic illness.
    Kovasznay B; Bromet E; Schwartz JE; Ram R; Lavelle J; Brandon L
    Hosp Community Psychiatry; 1993 Jun; 44(6):567-71. PubMed ID: 8514304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotic symptoms in patients with borderline personality disorder and concurrent axis I disorder.
    Miller FT; Abrams T; Dulit R; Fyer M
    Hosp Community Psychiatry; 1993 Jan; 44(1):59-61. PubMed ID: 8436363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of dual diagnosis. Substance dependence and psychiatric disorders.
    Bryant KJ; Rounsaville B; Spitzer RL; Williams JB
    J Nerv Ment Dis; 1992 Apr; 180(4):251-7. PubMed ID: 1556565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
    Liraud F; Verdoux H
    Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence and clinical correlates of psychiatric comorbidity in patients with psychotic disorders.
    Cassano GB; Pini S; Saettoni M; Rucci P; Dell'Osso L
    J Clin Psychiatry; 1998 Feb; 59(2):60-8. PubMed ID: 9501887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidity of substance abuse and schizophrenia: the role of pre-morbid adjustment.
    Arndt S; Tyrrell G; Flaum M; Andreasen NC
    Psychol Med; 1992 May; 22(2):379-88. PubMed ID: 1615105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abuse of psychoactive drugs and social adjustment of psychotic patients].
    Lépine A; Côté G
    Can J Psychiatry; 1998 Dec; 43(10):1036-9. PubMed ID: 9868570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
    Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
    Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.